CAS: 2097381-85-4
![(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-me…](https://static.cymitquimica.com/products/IN/thumb/DA01DDMJ.jpg)
(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
CAS:2097381-85-4
Formula:
C27H33N5O4S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
523.6470
Ref: IN-DA01DDMJ
| 1g | To inquire | ||
| 1mg | 114.00 € | ||
| 2mg | 169.00 € | ||
| 5mg | 179.00 € | ||
| 10mg | 198.00 € | ||
| 50mg | 328.00 € | ||
| 100mg | 583.00 € | ||
| 250mg | 618.00 € | ||
| 500mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
VH-298
CAS:2097381-85-4
VH-298 blocks VHL:HIF-α interaction, stabilizes HIF-α, and triggers hypoxic response differently by inhibiting VHL post-HIF-α …
Formula:
C27H33N5O4S
Purity:
100% - 99.17%
Color and Shape:
Solid
Molecular weight:
523.65
Ref: TM-TQ0121
| 2mg | 46.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 214.00 € | ||
| 50mg | 348.00 € | ||
| 100mg | 578.00 € | ||
| 1mL*10mM (DMSO) | 92.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
VH 298
CAS:2097381-85-4
A selective VHL inhibitor that stabilizes the hydroxylated form of HIF-α, resulting in upregulation of …
Formula:
C27H33N5O4S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
523.65 g/mol
Ref: 3D-BV165083
| 10mg | 329.00 € | ||
| 50mg | 922.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
